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Summary. Fluorescence polarization measurement during the progress of
fluorochromasia has been used to study the response of human lymphocytes to
phytohaemagglutinin (PHA) and to tumour-associated antigens, as a basis for the
detection of malignant disease.
Polarization (P) values of both stimulated and unstimulated lymphocytes de-
creased with increasing intracellular fluorescence intensity, and with the duration of
the fluorochromatic reaction. When these effects were taken into account, there was
no significant difference in the change of P following stimulation oflymphocytes from
50 cancer patients or healthy subjects; the magnitude of the response was related
more to the age of the donor and to the extent of granulocyte contamination of the
lymphocyte preparation than to the presence of cancer.
There were, however, significant differences in the change in leakage of fluorescein
out of the lymphocytes and in the change in hydrolysis rate after PHA stimulation
between lymphocytes from healthy individuals and from patients with cancer.
A NUMBER of in vitro methods exist to
demonstrate cell-mediated immune re-
sponses to antigens in animals and man
(Bloom et al., 1973; Rocklin, 1974). The
basis of many of these methods is the
interaction of sensitized lymphocytes with
the specific antigen, to release biologically
active susbtances (Pick & Turk, 1972)
whose presence may be detected by their
effect on other cell types (Morley et al.,
1973).
In 1970, Field & Caspary presented
evidence that lymphocytes from patients
with malignant disease were sensitized in
the above manner to basic proteins derived
from malignant tumour tissue. They in-
troduced a novel method for detecting
lymphocyte sensitization which relied on
cell electrophoresis, and subsequently
became known as the Macrophage Electro-
phoretic Mobility (MEM) test (Pritchard
et al., 1973). Results with this technique
could be obtained more quickly than with
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any previously described method. The test
relied on the in vitro reaction of lympho-
cytes from patients with malignant disease
with a cancer basic protein (CaBP) or with
a brain-derived protein (encephalitogenic
factor, EF) to release a substance which
reduced the surface charge on guinea-pig
macrophages or other target cells, and
could hence be detected by their subse-
quently reduced electrophoretic mobility.
However, although their observations
were at least partially confirmed in some
laboratories (Pritchard et al., 1973; Preece
& Light, 1974), the test was technically
difficult, and several groups reported that
it was too unreliable to be of any clinical
use (Lewkonia et al., 1973; Forrester et al.,
1977). The potential applications for a
simple rapid test in which malignanev can
be detected at an early stage in its devel-
opment are obvious and far-reaching.
Therefore, the description by Cercek et al.
(1974) of the use of fluorescence-polariza-P. BALDING, P. A. LIGHT AND A. W. PREECE
tion ineasuremenits to detect lymphocyte
sensitization caused widespread interest.
In their test system, measurement of
fluorescence polarization (P) of fluorescein
molecules in the cvtoplasmic matrix
following fluorochromasia (Rotman &
Papermaster, 1966) was used to demon-
strate the response ofhuman lymphocytes
to the mitogein phytohaemagglutinin
(PHA) or to the cancer basic protein
(CaBP) and encephalitogenic factor (EF)
used in the MEM test. Their earlier studies
on yeast cells (Cercek & Cercek, 1972,
1973) and on Chinese hamster ovary cells
(Cercek et al., 1973) had indicated that
there existed a relationship between
fluorescence polarization of fluorescein
molecules (produced by enzymatic hydro-
lysis of the non-fluorescing fluorescein
diacetate, FDA) in the cytoplasmic matrix
and the average microviscosity of the
lymphocyte cytoplasm. Their investiga-
tions using this technique were then ex-
tended to human lymphocytes, and their
results indicated that the responses of
lymphocytes from patients with malignant
disease to CaBP and EF and to PHA were
different from those of lymphocytes from
normal subjects. Such responses were
observed after a very short exposure to
antigen or mitogen; lymphocytes from
cancer patients showed a 20% decrease in
P value within a 5min exposure to CaBP
or EF, and lymphocytes from healthy
donors showed a similar response to PHA
but not to EF or CaBP. They called this
test the Structuredness of Cytoplasmic
Matrix (SCM) test.
The SCM test as described by Cercek
et al. (1974) and subsequently modified
(Cercek & Cercek, 1977) has been con-
firmed by Takaku et al. (1977) and
Pritchard & Sutherland (1978). The lack
of response to PHA of lymphocytes from
cancer patients has been confirmed by
Kreutzmann et al. (1978). In a later study,
Pritchard et al. (1978) reported that
lymphocytes from cancer patients did
show a response to PHA, but that the
differential between cancer and non-
cancer lay in the different responses of
high- and low-density lymphocytes. How-
ever, Dickinson et al. (1976) and Bockle-
hurst, Pentycross and others (see Bag-
shawe, 1977) have been unable to confirm
the results using the original technique of
Cercek et al. (1974) and Dickinson, Penty-
cross and Stack-Dunne (personal com-
munications) have also been unable to
reproduce the SCM test using the modified
technique of Cercek & Cercek (1977).
This study sought to examine the
differential PHA response of lymphocytes
from healthy donors and patients with
malignant disease, and to attempt to
detect any response to CaBP or EF by
lymphocytes from such patients, whilst
taking note of the progress of fluoro-
chromasia in these cells.
MATERIALS AND METHO1)S
Preparation of cell suspension.8
Human lymphocytes were prepared from
20 ml peripheral blood containing preserva-
tive-free heparin (15 u/m]). Either imme-
diately after collection (preparation technique
a) or after first allowing the blood to stand
overnight at ambient temperature (prepara-
tion technique b) the blood was incubated
with -100 mg iron carbonyl (Grade SF,
GAF Ltd) at 37°C for 20 min with continuous
gentle mixing. After sedimentation of the
iron carbonyl-containing cells on a magnet,
an approximate ESR (erythrocyte sedimenta-
tion rate) was noted and the temperature of
the blood was adjusted to 25°C (prep. a) or
13°C (prep. b) bystanding in a waterbath. The
lymphocytes contained in the supernatant
were then separated at 25°C (prep. a) or
13°C (prep. b) on a Ficoll-Triosil solution
(density = 1-081 g/cm3, osmolality-320
mOsm and 300 mOsm, respectively, at those
temperatures) and centrifuged at 550 g for
20 min, as described by Cercek & Cercek
(1977). Lymphocytes were collected byremov-
ing only the band of cells floating above the
Ficoll-Triosil solution with a saline-rinsed
Pasteur pipette, care being taken to remove
as little plasma or Ficoll-Triosil as possible,
and washed twice in sterile saline (Baxter
Division, Travenol Labs, Thetford).
Prep. a cells were then washed twice in
Medium 199 with Earle's salts, 25mM HEPES
and L-glutamine (Gibco Biocult Ltd). Prep.
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b cells were washed twice in PBS (complete
Dulbecco phosphate-buffered saline (pH 7-3)
from Oxoid Ltd code SR 38 plus code BR
14a) the osmolarity of which was adjusted to
330mOsmwithNaCl, before filtrationthrough
a Millipore filter, 0 45,um pore size (cat. no.
HAWP 02500). Lymphocytes were resus-
pended in fresh Medium 199 or PBS as
appropriate, at a concentration of 4 x 106/ml.
Cell suspensions were examined under the
phase-contrast microscope, and total lympho-
cytes, erythrocytes and granulocytes were
counted.
At this stage samples were relabelled by a
person not involved in the experimental
procedure, in order to overcome possible
subjective bias associated with the observed
raised ESR in blood samples from patients
(see later).
Lymphocyte stimulation
Cells suspensions were allowed to stand at
ambient temperature for about 2 h after
preparation. Lymphocytes were then incu-
bated for 30 min at 37°C with (1) 0-1 ml
sterile saline for the unstimulated sample, (2)
with 0-1 ml of reconstituted reagent grade
PHA (Wellcome Reagents) diluted x 5 in
sterile saline for PHA stimulation, (3) with
25 ,ug of EF or CaBP contained in 0-1 ml
sterile saline, for tumour-associated antigen
stimulation. EF (from human brain) and
CaBP (from carcinoma bronchus tissue ob-
tainedpost mortem) prepared bythe method of
Caspary & Field (1971) were of known acti-
vity, and were used concurrently in the
MEM test (Preece & Light, 1974) during the
course of this investigation.
Measuremenet of fluorescence polarization and
intensity
Fluorescein diacetate (FDA; Koch-Light
Laboratories) was dissolved in acetone
("Aristar" Grade; British Drug Houses) at a
concentration of 5 mg/ml. For use as a sub-
strate in the spectrofluorimeter, 10 /d of this
solution was added to 50 ml of Millipore-
filtered PBS (osmolarity not adjusted to
330 m Osm for prep. a cells only); the sub-
strate solution containing 2 4x 1O-6M of
FDA was equilibrated to 27°C before the
addition of cells to an appropriate volume of
substrate to give a final lymphocyte concen-
tration of 1-3 x 105/ml. This cell suspension
was maintained at 27°C and 3ml aliquots
were pipetted into the cuvette, also main-
tained at 27°C, after a known duration of
hydrolysis. Subsequent filtration of the
suspension was carried out using 0-22[tm
pore-size Millipore filters (Cat. No. GSWP
02500) in Millipore Swinnex 25 holders, or
0-45,um pore-size filters (Cat. No. HAWP
01300) in Swinnex 15 holders, using suction
limited to 50 kPa.
Measurements of fluorescence polarization
were made with two different instruments:
Perkin Elmer MPF 3L Spectrofluorimeter,
and later, for part of the series using cells of
prep b, a Perkin Elmer MPF4. The excitation
wavelength used was 470 nm (20 nm band-
width) and the emission wavelength used was
510 nm (10 nm bandwidth). A Baird-Atomic
FITC barrier filter (cut off below 505 nm) was
used in the emission light path to reduce
unwanted scattered light to negligible levels
(less than 2% at the maximum spectrofluori-
meter gain setting used). Excitation intensity
was increased in both instruments by incor-
porating a 1-wave plate (Polaroid, Polarizers,
U.K.) at the correct angle in the excitation
beam; a '-wave plate (Polaroid) was also
used in the emission beam of the MPF 3L to
correct the G factor from 0 77 to 1P0, to
facilitate interpretation of the chart recorder
traces. Polaroid HN 32 polarising filters
(cross-over extinction less than 0 02% of the
parallel transmission) were used as analysing
filters.
For comparison, some studies were carried
out with a Perkin Elmer 4F spectrofluori-
meter at Cambridge (by kind permission of
Prof. N. Bleehen) using the same experi-
mental procedures as described above, and
further studies were carried out with another
Perkin Elmer MPF 4 at Cardiff, (by kind
permission of Dr J. A. V. Pritchard) but
using procedures as described by Cercek et al.
(1974) as modified by Cercek & Cercek (1977);
FDA was used at a concentration of2-4 x 10-6
M. In all instruments a cuvette with a light
path of 10 mm w%ias used.
Polarization of emitted light, P, was meas-
ured at right angles to the polarized excita-
tion beam as:
PIvv-GIvH Ivv+GIvH
where lvv and IVH are the fluorescent inten-
sities observed parallel and perpendicular
respectively to the polarization of the excita-
tion beam, and G is the grating factor deter-
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mined experimentally for each machine.
Total fluorescence intensity Ft and extra-
cellular fluorescence intensity Fs were calcu-
lated from the basic equation:
F=Ivv+2 GIVH-Fo
where Fo is the contribution to the fluores-
cence intensity from spontaneous hydrolysis
of the FDA substrate, measured after an
appropriate time using substrate solution
without added cell suspension. The intra-
cellular fluorescence intensity, Fi=Ft-F,
When Fi= 1000 u, the equivalent average
concentration of fluorescein per cell is
'2-5 x 1O-4M (1000 u of fluorescence is
emitted by 8 x 10-9M NaF). Change in
polarization values (AP) with duration of
hydrolysis and intracellular fluorescence in-
tensity was calculated as follows: The P for
at least 8 increasing lengths oftime ofhydro-
lysis was plotted against duration of hydro-
lysis and against the intracellular fluorescence
value (Fi) for each value of P. The P values
corresponding to 2 min, 5 min, 10 min, 15
min, and 20 min hydrolysis were taken from
the graph for the unstimulated cells and com-
pared with values obtained for equal times
using "stimulated" cells. The mean difference
was expressed as %AP (time). Similarly
%AP (FI) was determined from Fi values of
200, 600 and 1200 u of fluorescence. The %
change in leakage with time and with Fi was
calculated in the same way. The % change
intotalhydrolysis rate (%AFt) was calculated
by comparing the average rate/min over
20 min ofhydrolysis; the %AP with time for
unstimulated cells was calculated by expres-
sing the difference between the P at 20 min
and the P at 1 min as a °h ofthe latter.
Subjects
The malignant group consisted of in-
patients with carcinomas, sarcomas and
lymphoma. Each had diagnosed disease with
tumour present, had not yet started radio-
therapy nor had had recent or extensive
chemotherapy; age range was 27-84 years.
The healthy subjects were volunteer hospital
staffselected to cover a wide age range (25-55
years).
RESULTS
Fluorochromasia in cell suspensions
Addition of lymphocytes to FDA sub-
strate produced an immediate increase in
fluorescent intensity; the minimum dura-
tion of hydrolysis which permitted calcu-
lation of fluorescence and P was found to
be about 1 min. As shown for a typical
healthy control sample in Fig. 1, the rate
10 15
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FIG. 1 -Fluorochromasia in human lympho-
cytes and the relationship between polariza-
tion of fluorescence and duration of FDA
hydrolysis at 27°C.
of hydrolysis of FDA to fluorescein is
almost linear, but the rate ofaccumulation
of intracellular fluorescein (Fi) gradually
decreased to a plateau after 14 min. The
extracellular ("supernatant") fluorescence
gradually increased from 12% to 56% of
total fluorescence (Ft) over 20 min. P
tends towards a plateau simultaneously
with the F1 values. Reproducibility for
unstimulated lymphocytes from a single
0 20
3 6 9 12 15 18 21
DURATION OF HYDROLYSIS (MINI
FIG.2. Relationship between polarization of
fluorescence and duration of hydrolysis for
unstimulated lymphocytes from 16 healthy
controls (0-0). Results for lymphocytes
from 16 patientswith malignant disease (0*)
are included for comparison. (+ s.e.).
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FIG. 3. Relationship between polarization of
fluorescence and intracellular fluorescence
for unstimulate(l lymplhocytes from 16
lhealthy controls (0 - 0). Results for
lymphocytes from 16 patients witlh
malignant disease (0*) are include(d for
comparison (± s.e.).
donor tested 3 times on the same day was
better than + 2.5% (s.d.). The mean
variation in P for lymphocytes of 16
healthy controls corresponding to in-
creased duration and Fi values is shown
in Figs 2 and 3. P values of unstimulated
lymphocytes from 16 patients with malig-
nant diseases are included for comparison.
Thus the experimental technique used
here permitted the calculation ofa number
of different parameters in addition to P
and 00AP after incubation oflymphocytes
with PHA, CaBP or EF.
Such parameters included:
(i) 00 change in average hydrolysis rate
over 20 min (AFt/min) for stimulated
compared with unstimulated lymphocytes.
(ii) 00 change in P of unstimulated
lymphocytes with duration of hydrolysis.
(AP 1-20.)
(iii) 00 change in P of stimulated com-
pared with unstimulated lymphocytes
averaged over several values for duration
of hydrolysis (AP (time)) and (iv) aver-
aged over several values for intracellular
fluorescence intensity (AP (Fi)).
(v) A leakiness (time) and (vi) A leaki-
ness (Fi):% change in leakiness of stimu-
lated lymphocytes calculated in the same
way as (iii) anid (iv).
Effect of overnight storage of blood samples
onP
Initially lymphocytes were prepared
from blood samples immediately after
collection. However, we learned that
lymphocytes used in the SCM test were
often isolated from blood samples collected
from donors on the previous day (L.
Cercek, personal communication). There-
fore blood samples were intentionally
stored overnight at ambient temperature
prior to isolation of lymphocytes. As
shown in Fig. 4, such treatment produced
an increased response to PHA, so all
samples were stored overnight prior to
isolation of lymphocytes using prep. b.
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FIG. 4. Effect of overniglht storage of blood
samples on change in fluorescence polariza-
tion following PHA stimulation of lympho-
cytes from healthy controls (mean of 2
experiments on 2 donors +s.e.).
Effect of incubation with PHA
Results for healthy controls and for 16
patients with malignant disease are shown
in Tables I to IV.
The mean percentage change in P with
duration of hydrolysis after incubation
with PHA for 30 min at 37°C was a
decrease of 8-4+ 18 (s.e.) for patient
samples, compared to a decrease of 11-9 +
1-5 for healthy control samples. This
difference is not significant (0.05 <P < 0 1).
However, there is a simultaneous change
in FDA hydrolysis rate (+10 3 + 4-4 for
healthy control samples, compared with
+0 6+ 3-3 in patient samples) and in
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TABLE I.-Cellyieldsand %changeinpolarizationoffluorescencewithtimeofunstimulated
lymphocytes and after incubation with PHA or EF. Samplesfrom healthy individuals
AP (time) AP (Fi) Cell _ , ,s , yield
PHA EF PHA EF X 10-6
- 7 1 - -2 1 20
- 49 + 21 + 38 +107 24
-156 + 4-0 -11-6 +135 24
-16 3 - -124 18
-13 5 -11-2 32
-11 6 + 20 - 49 + 58 22
-20 1 - 9 8 24
-15 1 -10*9 22
-11 6 - -130 21
- 9.4 - 1.1 - 0.5 - 25 22
+ 3d1 +11b7 16
-19.5 - 6-5 16
-153 - 9*3 -140 - 7-0 20
-19 4 -16 5 10
- 4.5 + 27 + 42 + 58 19
9.7 -121 - 24
-11 9 + 0.1 - 6-6 + 44 21
1.5 1-8 1.9 2-9 1-2
% cells*
Ly E G
80 15 5
79 15 6
79 16 5
75 20 5
50 24 26
76 12 12
65 25 10
74 18 8
78 17 5
* Ly =Lymphocytes; E =Erythrocytes; G =granulocytes.
TABLE II.-Change inFDA hydrolysis rate and in leakage offluorescein out oflymphocytes
after incubation with PHA or EF, expressed as % ofunstimulated values. Samplesfrom
healthy individuals
Age AFt rate/min
and , -
sex PHA
- 7 5
+ 13 5
+ 12 2
+5 6
+ 4-0
+5 2
+ 12 6
+4 4
- 2 0
-6 1
+ 36 6
+ 18 8
- 0 8
+640
+ 12-1
-8 6
+ 10-3
4.4
25F
26F
29M
30M
33M
34M
36M
38M
43F
47M
50M
51F
5iM
54M
54M
55F
Mean
s.e.
A Leak (t
EF PHA
-7 8
+5 0
-0 6
+2 8
+ 15-0
+ 11 3
+4 9
3 1
-8 8
-44
- 538
-362
-10 6
-6 2
-4-0
- 1-2
4 8
-3 8
-6*4
-5 1
0 7
ime) A Leak (Fi)
EF PHA EF
-7 3 _
+1-0 -6-3 +23
+22 -11.0 0
-3.7
-0 8 -13 7 -3.7
-9.5
-
73
-8 7
+4 1 -1-6 +0-3
- -3.7
- -3.7
+0-4 +1 3 +1 7
-9 7
+56 -7-0 +1 7
-2 0
+2 1 -6 5 +0-4
0.9 1.0 0-8
leakage of the fluorescein out of the
lymphocytes (-5-1 + 07 with duration
and - 65 + 1 0 with Fi levels for healthy
control samples, and zero change with
duration or + 08 + 1P3 with Fi levels for
patient samples) which taken together
give an increase in Fi, especially in healthy
control samples. As shown in Fig. 5 the
change in P is proportional to the Fi level
in unstimulated lymphocytes, so a com-
parison of P changes has to be made on
the basis of similar Fi intensities. Such
values of %AP for healthy control
samples and patient samples respectively
are -66 + 1P9 and -77 + 19.
Thus although there is a real decrease
Age
and
sex
25F
26F
29M
30M
33M
34M
36M
38M
43F
47M
50M
51F
5iM
54M
54M
55F
Mean
S.e.
AP
(1-20 min)
unstim.
-23 5
-205
- 18 9
-11-4
-195
- 29 6
- 22-6
-16 4
- 32 2
-26 9
- 26 4
- 15 6
-21 8
-22 8
-23-7
-27 6
-22 5
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TABLE III.-Cell yields and % change inpolarization offluorescence (AP) ofunstimulated
lymphocytes and after incubation withPHA or EF. Samplesfrompatients withmalignant
disease
a) AP (Fi)
EF PHA EF
-2 7
+ 5 6
+6 8
+0 8
+0 8
+2-5
1.5
-15-2
-1 6
- 3.3
+ 7 4
- 6 2
-19 4
-10 2
-6 8
-12 3
+ 2-4
-0o9
- 4.3
- 2 5
-21 0
-13 1
-15 6
7.7
1-9
-2 6
+ 12-2
+9 4
+ 1.0
+0 2
+40
2 6
Cell
X 10-6
yield
7
15
10
17
159*
17
10
12
24
15
11
18
14
14
17
17
14 5
1-0
% cells
Ly E G
59 26 15
72 19 9
59 35 6
78 11 11
89 6 5
48 49 3
- - 12
7
79 15 6
5
- - 10
57 22 21
29 67 4
- - 25
3
65 25 12
* Not included in mean of cell yield-patient had leukaemia.
TABLE IV.-Change in FDA hydrolysis rate and in leakage offluorescein out of lympho-
cytes after incubation with PHA or EF, expressed as % ofunstimulated values. Samples
from patients with malignant disease
Age AFt rate/min A Leak (time) A Leak (Fi)
and
A A
sex PHA EF PHA EF PHA EF
27F -7-0 - -3-8 - -1-3
30M +7-0 -5.0 -6-0 +0-2 -5.0 +2-3
33M +11-0 +3-0 +1-6 +0-2 +1-3 +1-6
43M +17-0 +5-0 -2-2 -0-2 -2-7 + 1-0
47F -0-8 - +3-6 +4-0
52F +2-0 -2-6 -11-3 -
55F -26-0 -3-8 -4-3
61M + 24-0 -9-0 -10-2 -2-6 -1 0 -1-3
65M -8-0 +3-0 +1-3
67M +2-0 0-0 - +10 -
69F +13-0 - -4-6 -5.
70M -16-0 -15-0 +3-0 +11-2 -1-0 +15-3
71M +17-0 +3-6 +3-0
73F +10-0 +5-2 +1-3 -
81M -15-0 +2-2 +12-3 -
84F -3-0 +0-6 -1-3 -
Mean +0-6 -4-2 0-0 +1-8 -0-8 +3-8
s.e. 3-3 1-9 0-8 2-2 1-2 2-6
in P corresponding to a net decrease in
cytoplasmic viscosity of the lymphocyte,
this change is relatively small, and is
almost identical in samples from both
healthy controls and cancer patients.
From these results it also appears that
there is a general trend to an increase in
the magnitude of AP after PHA incuba-
tion, both with decreasing age of the
6
sample donor, and with an increase in
granulocyte contamination (a plot of
%A\P vs % granulocyte contamination
has a correlation of 0-61 and a slope of
0.64). Erythrocyte contamination does not
appear to influence AP, but the PHA
response might be reduced when much lar-
ger numbers of erythrocytes are present,
since the concentration of PHA available
Age
and
sex
27F
30M
33M
43M
47F
52F
55F
61M
65M
67M
69M
70M
71M
73F
81M
84F
Mean
s.e.
AP
(1-20 min)
unstim.
-23 0
-25 7
-2563
-19 3
- 20 6
-24-3
-15 9
-24-9
-18-5
-34-1
-14 9
-16 7
-17 8
-29-1
-16-2
-32-2
-22 4
1 4
AP (time
_
--
PHA
-13 2
-5*6
-4.7
+2 4
-5.7
-15 2
-11-7
-6 3
-11*4
+0 6
-5.9
-8-2
-6 3
-27 0
-50
-157
-8-4
1 8
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Effect of variation in preparation of
lymphocytes
For the purpose of comparing the earlier
(prep. a) and later (prep. b) techniques for
cell preparation, samples from 9 healthy
controls and 9 patients with cancer were
processed using the original technique for
cell preparation (prep. a) described by
Cercek et al. (1974) but with two modifica-
tions. (i) We used Ficoll-Triosil of density
/1081 g/cm3 originally used in error by the
group but subsequently shown to be
critical (reported by L. Cercek at the
___,________,__,_,__,_,__, BACR workshop in 1976; see Bagshawe,
200 400 600 800 1000 1200 1977). (ii) We used Gibco Biocult Medium
INTRACELL FLUORESCENCE (Fi) 199 containing 2mM HEPES and L-
ependence of polarization clhanges glutamine rather than TC 199 (Wellcome
cellular fluorescence levels for un- R s
lvImphocvtes from 1; 6healthy heagents) since we found the pH of the
latter to be unstable during incubation of
lymphocytes at 37°C and the cells were
prone to clumping. Results showing P
ywith lymphocytes would be against duration of lhydrolysis and Fi for
r absorption. For the samples unstimulated lymphocytes, and after in-
Fables I and III, the effect of cubation with PHA or EF are shown in
e contamination is insignificant Figs 6-9. The results were not significantly
to that caused by granulocyte different comparing healthy controls with
tion. patients, nor were they different when
comparing the cell preparation techniques
cubation with CaBP and EF (a and b) except that when the higher-
3onses to both CaBP and EF osmolarity PBS was used for cell suspen-
,ical, so only results with EF sion, there was a smaller increase in P
+a rl rpLava l1rQo rwr 1;++1I" after incubation with EF. AI-e pi-esetelu. ineroe was very iu-uie
difference in response of lymphocytes
isolated from either patients or controls.
As found using PHA any small difference
(lisappeared when AP with Fi was com-
pared. Similarly, the effects of incubation
with EF on FDA hydrolysis rate and
leakage of fluorescein out of the cells were
significantly different, but it is unlikely
that these differences could be of anv
diagnostic use.
The mean values for 00 leakage of
fluorescein out of unstimulated lympho-
cytes from both healthy controls and
patients with cancer were not significantly
different (37.0+ 1 0 and 36-0+ 1 6 res-
pectively) nor was the AP with duration
of hydrolysis (-22.5 + 1P3 and-22-4 + 14
respectively).
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FIG. 6. Change in fluorescence polarization
with increasing duration of FDA hydrolysis
and after PHA and EF stimulation for
lymphocytes from 9 healthy control sub-
jects. Lymphocytes were washed and
incubated in Med'iulm 199 (prep. a).
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FiG. 7.-Change in fluorescence polarization
with increasing intracellular fluorescence
intensity, in unstimulated and after PHA
and EF stimulation of lymphocytes from 9
healthy control subjects. Lymphocytes
were washed and incubated in Medium 199
(prep. a).
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ment and hydrolysis was allowed to pro-
ceed for different lengths oftime. P values
determined in this way are more suscept-
ible to experimental variation than when
the bulk hydrolysis method is used. As
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FIa. 8.-Change in fluorescence polarization
with increasing duration ofFDA hydrolysis
and after PHA and EF stimulation for
lymphocytes from 9 cancer patients. Lym-
phocytes were washed and incubated in
Medium 199 (prep. a).
Results with other spectroftuorimeters
Results obtained using the spectro-
fluorimeters in Cambridge and Cardiff
were in agreement with those obtained
using the MPF 3L and MPF 4 instruments
in Bristol. The bulk substrate-cell suspen-
sion technique described here was not
used; an appropriate volume of lympho-
cyte suspension was added to 3 0 ml of
substrate immediately before measure-
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Fia. 9.-Change in fluorescence polarization
with increasing intracellularfluorescence in-
tensity in unstimulated and after PHA and
EF stimulation of lymphocytes from 9
cancer patients. Lymphocytes were washed
and incubated in Medium 199 (prep. a).
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FIG. 10.-Relationship between fluorescence
polarization and duration of hydrolysis,
measured using the MPF 3L spectro-
fluorimeter in Bristol (0- - -0) and the
MPF 4 in Cardiff (0-0). P values were
measuredindividuallyforincreasingperiods
of time rather than by the bulk suspension
method.
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shown in Fig. 10 there is little difference in
the dependence of P upon duration of
hydrolysis, whether measured in Cardiff
using the MPF 4, or in the same way using
our MPF 3L in Bristol.
Raised ESR and samplesfrom patientts
Samples were obtained from either
healthy laboratory staff or from patients
with advanced malignant disease. In two
such artificially distinct groups it was
therefore not surprising to find that blood
samples supplied "blind" could be easily
identified as "healthy" or "patient" on
the basis of raised erythrocyte sedimenta-
tion rate (ESR). Out of 50 samples de-
scribed in this study, only one sample from
a "healthy" donor (aged 43) with no
unusual medical history had a raised
ESR, thus a 980o accurate diagnosis
could be claimed in a comparison of such
samples. For this reason samples were
relabelled and supplied "blind" after
preparation of cell suspensions.
DISCUSSION
Each ofthe cell samples studied showed
a change in P with time, reaching a
plateau at the higher concentrations of
fluorescein, whilst simultaneously the rate
ofaccumulation ofintracellular fluorescein
appeared to be decreasing while the actual
hydrolysis rate remained almost linear.
(This pattern was found with all cell
samples tested.) Similar effects have re-
cently been noted by other workers (M.
Stack-Dunne, H. Mitchell, personal com-
munication).
We found no marked differences be-
tween results from the various spectro-
fluorimeters used, other than those due to
different sensitivities. Rigidly controlled
conditions were found to be extremely
important for reproducibility. Failure to
allow the cuvette and substrate to equili-
brate in temperature before introduction
of the cells to the substrate was found to
generate an apparently linear hydrolysis
curve on the chart recorder trace rather
than the more usual convex one, and re-
sulted in raised P estimates. Cercek &
Cercek (1 976a) have previously noted that
P may be increased by hyperosmotic
buffer solution, or by high Ca++ or Mg++
concentrations. The method used here for
the incubation of cells with substrate was
devised to minimize experimental varia-
tion due to pipetting errors; aliquots of
cell suspension taken from the bulk incu-
bation mixture gave more consistent re-
sults than those obtained using the tech-
nique described by Cercek et al. (1974) or
as modified by Cercek & Cercek (1977).
Lymphocytes from human blood were
isolated using Ficoll-Triosil of density
1081 g/cm3, since this density was
described as critical by Cercek & Cercek at
the BACR workshop, 1976, and by Cercek
& Cercek (1977). The exact nature of the
differences between the cell populations
derived from Ficoll-Triosil of density
1 077 g/cm3 and density 1081 g/cm3 has
not been investigated in detail, but from
direct observation in the microscope and
from the electrophoretic-mobility values
obtained in this laboratory, it is found
that lymphocytes isolated on Ficoll-
Triosil of density 1081 g/cm3 have a
greater contamination with granulocytes
than those from the density 1 077 g/cm3
Ficoll-Triosil. In young healthy donors
especially, this may cause a much larger
AP after PHA incubation than obtained
using a pure suspension of lymphocytes.
The increase in response to PHA observed
in lymphocytes from samples stored over-
night may be due to an increase in the
number of granulocytes contaminating
these samples.
It is tempting to ascribe the observed
change in P with increasing time to a con-
centration depolarization effect (Dale &
Bauer, 1971). The distribution of fluores-
cein within the cell is a matter of con-
jecture, not accurately known, since cal-
culations based on known (or extra-
polated) fluorescein concentrations take
into account only intra- and extracellular
volumes, and ignore interaction between
fluorescein and membranes or enzyme
sites. It is likely, therefore, that any cal-
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culation of fluorescein concentration will
underestimate the actual local concentra-
tions. Two hypotheses may be considered
to explain the observed change in P with
time. One possibility is that fluorescein, as
formed, is redistributed intra-cellularly
from a rigid to a more aqueous phase, thus
reducing the average observed P. A
second possibility is that fluorescein may
attain sufficiently high local concentration
for quenching to be significant, with asso-
ciated depolarization.
The rate of fluorescein production
appears to be linear (Fig. 1). A saturation
curve for fluorescein within the cell is also
shown in Fig. 1. The limiting value of
fluorescence may arise when the rate of
diffusion of fluorescein out of the cell
approaches its rate of production. It is
possible that FDA transport into the cell
is competitively blocked by fluorescein, if
both have affinity for the same structure
involved in membrane transport (as pro-
posed by Steen & Lindmo, 1976). The
apparent alteration in intracellular accu-
mulation of fluorescein could be due to
feedback inhibition by the reaction pro-
ducts. However, the total fluorescence
was observed still to be increasing when
intracellular fluorescence was at a plateau
level, suggesting that saturation or
quenching may be more important than
inhibition ofFDA transport.
The fluorochromasia studies described
here have failed to reveal a stable P while
fluorescence levels are increasing; indeed,
there is a close link between P values and
intracellular concentrations of fluorescein
(Fig. 5) which in turn are dependent upon
the hydrolysis rate and the leakage of
fluorescein out of the cell. The curves
shown in Figs 3 and 5 are obtained using
a final FDA substrate concentration of
2.4 x 10-6M, with hydrolysis for 20 min at
27°C. Epstein et al. (1977) using a 10-fold
concentration of FDA at 22°C have also
found a decrease in P with increasing
intracellular fluorescence intensity for a
mouse leukaemia cell line (EL 4) cultured
intraperitoneally in C57BL mice. The
excitation A of 488 nm for their flow
system, and the use of an emission A other
than 510 nm was criticised by B. Cercek at
the 1976 BACR Workshop, and by Cercek
& Cercek (1977) on the grounds that a
specific fluorophor, which can only be
detected using an Xenon light source with
an excitation A of 470 nm and emission A
of 510 nm, is involved in SCM measure-
ments. Epstein et al. (1977) conclude, how-
ever, that their results are compatible with
those of Cercek et al. (1973) for CHO cells,
which form the basis of the SCM test
(Cercek & Cercek, 1977). The agreement
between our results obtained for human
lymphocytes using the light source and
wavelength combination defined by the
Cerceks, and those of Epstein et al. (1977)
indicate that these parameters may not
have a large effect on the measurements.
We have been able to confirm also the
response of P after PHA incubation to
lymphocytes from healthy human donors.
However, our observation of a response of
lymphocytes from patients with cancer to
PHA and ourfailure toobtainadifferential
response to EF or CaBP is not in agree-
ment with the results ofCercek et al. (1974)
and Cercek & Cercek (1977). There are
several possible reasons for these dis-
agreements:
(i) Our measurements take into account
the relationship between P and Fi and any
effect of PHA, or other antigen, altering
the rate of FDA hydrolysis or leakage of
fluorescein out of the cell. On the basis of
our results using 25 x 10-6M FDA sub-
strate as shown in Fig. 3, an increase in
the Fi concentration of only 50%O (e.g.
from 400 to 600 u) results in a decrease of
P of 7.7%. Similarly as shown in Fig. 2,
P decreases by 822% if the duration of
hydrolysis is increased from 4-5 to 9 0 min.
The presence of these effects suggests that
real changes in P may be obscured by
variable times of hydrolysis or accumula-
tion of intracellular fluorescein.
(ii) We have used a substrate concen-
tration of 25 x 10-6M FDA, prepared
from an acetone-based stock solution,
rather than a concentration of 0-6 x 10-6M
FDA prepared from a glacial-acetic-acid-
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based stock solution as advocated by
Cercek & Cercek (1977) who found that
certain batches of acetone contain im-
purities which result in lower P values and
responses to PHA or CaBP. However, all
the SCM measurements reported by Cercek
et al. (1974) and Cercek & Cercek (1977)
have also been made using the acetone
based higher FDA concentration.
In control experiments we obtained
higher P values using 06 x 10-6M FDA
substrate prepared from either acetone-
based or acetic-acid-based stock solution,
but there was little difference between
them, provided the pH and osmolarity of
the buffered saline were maintained. How-
ever, the fluorescence intensities achieved
were much lower than those using 2-5 x
10-6M FDA substrate, resulting in a de-
creased signal: noise ratio in the spectro-
fluorimeter which made the calculation of
P values more difficult. Thus, although the
P values obtained with a higher concen-
tration of FDA substrate are lower than
those obtained with a lower concentration,
the lymphocytes with lower P values are
not necessarily prestimulated by prepara-
tion procedures, as has been suggested
(Cercek & Cercek, 1977) but simply con-
tain more fluorescein. These results may
also provide an explanation of the single-
cell polarization measurements (Cercek &
Cercek, 1976b) where, in addition to the
histogram of individual P values, there is
a wide spread of fluorescence intensities.
(iii) It is possible that although we have
endeavoured to isolate only the lympho-
cyte layer containing the "responding"
population, as described by Cercek &
Cercek (1977) we have not been able to
isolate the particular low-density sub-
population described by Pritchard &
Sutherland (1978). From our results it
must be noted that the number of con-
taminating granulocytes in the "lympho-
cyte" cell suspension appears to affect the
change in P after PHA incubation. This
may be important, since the proportion of
granulocytes isolated from non-carbonyl-
iron-treated blood samples by the density
gradient method has been found to be
higher and to include some imnmature
forms, in cancer patients, compared with
healthy controls (Currie et al., 1978). As
can be seen from Tables I and III, not all
granulocytes are removed by treatment of
the blood sample with carbonyl iron.
In conclusion it is apparent that correct
evaluation ofSCM as a test for malignancy
does require a rigidly controlled experi-
mental procedure, particularly with con-
sideration of factors such as duration and
rate of hydrolysis and leakiness of cells.
The experimental procedure described
here attempts to take account of each of
these parameters. In addition the age of
the donor ofthe sample, proportion ofcon-
taminating cells particularly granulocytes,
and the inherent variation from subject to
subject of qualitative and quantitative
yields of cells, hinders comparative
studies. Taking into account these factors,
we are unable to reproduce the reported
differential responses of lymphocytes to
PHA or tumour-associated antigens.
The results illustrated in F'igs. 6-9 hiave been
previously reported at the 1978 meeting ofthe BACR
in Oxford, abstracts of which were published in this
journal (Preece, Light & Balding, Br. J. Cancer, 38,
1978).
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